Takeaway
- Enpatoran failed to reduce time to recovery in patients hospitalized with acute COVID-19 pneumonia, but it was safe and well-tolerated.
Why this matters
- Enpatoran is an investigational highly selective inhibitor of TLR7 and TLR8, which may potentially prevent a hyperinflammatory state and cytokine storm in patients with COVID-19 pneumonia....